Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT07442058
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Attention Deficit Disorder With Hyperactivity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Intermittent Theta-Burst Stimulation — DEVICETheta Burst Stimulation is a second-generation TMS modality. iTBS enhances cortical excitability, facilitating synaptic connections through putative long-term potentiation-like effects. In addition, iTBS also stands out given its favorable safety profile and its brief administration time.
- Sham Stimulation — DEVICESham will be administered using equivalent procedures but with a sham coil.
Study Details
Impaired inhibitory response manifests clinically as increased impulsivity, which leads to poorer affective, cognitive, social, and occupational functioning. Neuropsychiatric disorders prevalent among Veterans, such as Attention Deficit/Hyperactivity Disorder (ADHD), are associated with poor inhibitory control. The mainstay of clinical treatment for ADHD is psychostimulants, yet these medications have significant risks, including dependence and numerous side effects. Thus, novel and non-pharmacological therapeutic strategies are needed. Intermittent Theta Burst Stimulation, a newer form of transcranial magnetic stimulation, has emerged as a promising tool for modulating inhibitory neuronal circuits. This research proposal will investigate the feasibility and acceptability of iTBS on inhibitory control and impulsivity through a randomized controlled trial to inform clinical observations. The long-term goal is to improve impulsivity, social and occupational functioning, and enhance the quality of life for Veterans.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- Feb 2026
- Primary completion
- Oct 1, 2027
- Completion
- Jul 1, 2028
Study Design
- Enrollment
- 35 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Active StimulationActive iTBS includes two extended stimulation sessions, at 90% MT, with standard parameters (50Hz triplets every 200ms), each consisting of 3,600 pulses (19 minutes), with a 30-minute intersession interval.
- Sham Comparator: Sham StimulationSham will be administered using equivalent procedures but with a sham coil. The sham coil is specifically designed to match the active coil in appearance, sound, and scalp sensation, providing a credible sham experience, as observed in our prior studies.
Primary Outcome Measure
Feasibility measured by follow-up completion [ Time Frame: 6 weeks ]
Central Contacts
- Camila Souza A Cosmo, PhD(401) 273-7100
- Emily M Aiken, MA BS(401) 273-7100
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Providence VA Medical Center, Providence, RI | Providence | Rhode Island | 02908-4734 | Camila Souza A Cosmo, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Providence, RI
Related Studies
- Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)Recruiting · Massachusetts General Hospital · Charlestown, Massachusetts